Proceedings of the National Academy of Sciences · 1998 · 372 citations · 25 references
MedicinePharmacologyCell SignalingMolecular PharmacologyNeuropharmacologyG Protein-coupled Receptor SignalingOpioid AnalgesicsOpioid PharmacologyOpioid RegulationReceptor PharmacologyReceptor RegulationBeta-arrestin-mediated RegulationBeta-arrestin-mediated SignalingDesensitization In Opioid ReceptorsOpioid Receptor AgonistsOpioid Receptor DesensitizationPhysiological Basis Of TolerancePhysiological Tolerance MechanismsReceptors
mu opioid receptors are targets of native opioid peptides and addictive analgesic drugs. A major clinical liability of opiate drugs is their ability to cause physiological tolerance. Individual opiates, such as morphine and etorphine, differ both in their ability to promote physiological tolerance and in their effects on receptor regulation by endocytosis. Here, we demonstrate that arrestins play a fundamental role in mediating this agonist-selective regulation and that morphine-activated mu receptors fail to undergo arrestin-dependent uncoupling from cognate G proteins. Thus, highly addictive opiate drugs elude a fundamental mode of physiological regulation that is mediated by agonist-specific interaction of opioid receptors with arrestins.
25
β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Oscar B. Goodman, Jason G. Krupnick, Francesca Santini et al. · Nature · 1996 · 1.4K citations
Induction of mutant dynamin specifically blocks endocytic coated vesicle formation.
Hanna Damke, Toru Baba, Dale E. Warnock et al. · The Journal of Cell Biology · 1994 · 1.2K citations · Full text
β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Martin J. Lohse, Jeffrey Benovic, Juan Codina et al. · Science · 1990 · 1.2K citations